Clinical trials: Acral Melanoma That Has Been Removed by Surgery
Acral Melanoma That Has Been Removed by Surgery
The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery
This is a phase III randomized, control, multi-center study of recombinant humanized anti-PD-1 mAb in combination with CTLA4 mAb for injection compared to high-Dose interferon in patients with acral melanoma that has been removed…
- Trial name
- NCT04277663
- Testing
- IBI310+IBI308, IBI308, High-dose recombinant interferon a-2B
- Where
- China
- Volunteers
- 136 people
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.